Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants.

导出 OA

翻译打印收藏纠错

作者： A Jerrod,Anzalone ^[1] ; William H,Beasley ^[2] ; Kimberly,Murray ^[3] ; William B,Hillegass ^[4] ; Makayla,Schissel ^[1] ; Michael T,Vest ^[5] ; Scott A,Chapman ^[6] ; Ronald,Horswell ^[7] ; Lucio,Miele ^[7] ; J Zachary,Porterfield ^[8] ; H Timothy,Bunnell ^[9] ; Bradley S,Price ^[10] ; Sharon,Patrick ^[10] ; Clifford J,Rosen ^[3] ; Susan L,Santangelo ^[11] ; James C,McClay ^[12] ; Sally L,Hodder ^[10] ; National COVID Cohort Collaborative (N3C) Consortium

作者单位： University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[1] University of Oklahoma, Norman, Oklahoma, USA. ^[2] Maine Health Institute for Research, Portland, Maine, USA. ^[3] University of Mississippi Medical Center, Jackson, Mississippi, USA. ^[4] Christiana Care Health System, Newark, Delaware, USA. ^[5] University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA. ^[6] Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. ^[7] University of Kentucky, Lexington, Kentucky, USA. ^[8] Nemours Children's Health, Wilmington, Delaware, USA. ^[9] West Virginia University, Morgantown, West Virginia, USA. ^[10] Maine Health Institute for Research, Portland, Maine, USA.;Tufts University School of Medicine, Boston, Massachusetts, USA. ^[11] University of Missouri School of Medicine, Columbia, Missouri, USA. ^[12]

关键词 COVID‐19 Therapies Mortality National COVID Cohort Collaborative (N3C)SARS‐CoV‐2 Urban‐Rural Health